Literature DB >> 21966988

Quality of life in Chinese home-based advanced cancer patients: does awareness of cancer diagnosis matter?

Xiaoping Fan1, Hua Huang, Qiong Luo, Jiying Zhou, Ge Tan, Na Yong.   

Abstract

The aim of this study was to assess the quality of life (QOL) of Chinese home-based advanced-stage cancer patients and to evaluate the association between the disclosure of cancer diagnosis and QOL. An interview-based survey was conducted from December 2009 to June 2010 in the home-based hospice of the First Affiliated Hospital of Chongqing Medical University, China. The principal finding of this study demonstrated that patients who did not have knowledge of their diagnosis exhibited better physical and emotional QOL compared with those who had knowledge of their diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21966988     DOI: 10.1089/jpm.2011.0111

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  4 in total

1.  Association between prognostic awareness and quality of life in patients with advanced cancer.

Authors:  Karolina Vlckova; Kristyna Polakova; Anna Tuckova; Adam Houska; Martin Loucka
Journal:  Qual Life Res       Date:  2022-02-04       Impact factor: 4.147

2.  The impact on quality of life from informing diagnosis in patients with cancer: a systematic review and meta-analysis.

Authors:  Miao Wan; Xianggui Luo; Juan Wang; Louis B Mvogo Ndzana; Chen Chang; Zhenfen Li; Jianglin Zhang
Journal:  BMC Cancer       Date:  2020-07-02       Impact factor: 4.430

3.  Cancer physicians' attitude towards treatment of the elderly cancer patient in a developed Asian country.

Authors:  Angela Pang; Shirlynn Ho; Soo-Chin Lee
Journal:  BMC Geriatr       Date:  2013-04-16       Impact factor: 3.921

4.  Disclosure of cancer diagnosis in China: the incidence, patients' situation, and different preferences between patients and their family members and related influence factors.

Authors:  Yuxiu Liu; Jinhong Yang; Da Huo; Honghua Fan; Yufang Gao
Journal:  Cancer Manag Res       Date:  2018-07-23       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.